KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Newly Developed Piperidinyl Sulfamides as Tyrosyl-DNA Phosphodiesterase 1 (Tdp 1) Inhibitors, and Study of Anticancer Activity of Piperidinyl Sulfamides Derivatives and Seven-Membered Cyclic Sulfamide Analogs Using the National Cancer Institute 60 Human Cancer Cell Line (NCI 60) Screen

    Thumbnail
    View/Open
    Jun_ku_0099D_13177_DATA_1.pdf (15.66Mb)
    Issue Date
    2013-12-31
    Author
    Jun, Jung Ho
    Publisher
    University of Kansas
    Format
    322 pages
    Type
    Dissertation
    Degree Level
    Ph.D.
    Discipline
    Chemistry
    Rights
    Copyright held by the author.
    Metadata
    Show full item record
    Abstract
    Sulfur containing compounds have become increasingly important in the development of biological agents for pharmaceutical and industrial use. Cyclic sulfamides, in particular, have been found to be useful as cancer, HIV protease inhibitors and other therapeutic treatments. As the need for new and improved inhibitors is warranted by the serious cancer disease, the search for new synthetic pathways to access novel sulfamides is ongoing. To this end, the work discussed herein focuses on the synthesis of newly developed sulfamides utilizing the reductive amination and Mitsunobu reaction to generate novel chiral amino ester containing sulfamide compounds. These compounds are being screened for their biological activities as Tyrosyl-DNA phosphodiesterase 1 (Tdp 1) inhibitors and anti-cancer drugs. Initially, reductive amination, CSI coupling, and Mitsunobu reaction were employed to generate piperidinyl sulfamides, and these compounds were screened for Tdp1 inhibition. These compounds were submitted to Dr. Pomier's group at NIH to carry out the gel study to select active compounds. We also checked the binding effect through the protein docking study. In addition, these sulfamide compounds were screened from NCI 60-cancer cell lines to check the bioactivity and in vitro cytotoxicity evaluation. To understand anti-cancer activity of cyclic sulfamides, symmetric and unsymmetric seven-membered sulfamides compounds were tested in 60 cancer cell line from the National Cancer Institute. These compounds were made when I studied for the Master degree at the University of Kansas. RCM was employed to generate symmetric seven-membered cyclic sulfamides similar in structure to known active HIV protease inhibitor DMP 323. Functionalization of these compounds employing "robust S-linchpins" in conjunction with RCM yields an array of new S-heterocycles. Further work in sulfamides employed a combination of RCM with different coupling routes to generate unsymmetric seven-membered cyclic sulfamides with varied substitution in their P1/P1' and P2/P2' periphery in attempts to broaden the scope of this chemistry and to generate new biologically active compounds.
    URI
    http://hdl.handle.net/1808/19567
    Collections
    • Chemistry Dissertations and Theses [335]
    • Dissertations [4660]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    Login

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps